表紙
市場調査レポート

Handok Inc. : 製品パイプライン分析

Handok Inc. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 257901
出版日 ページ情報 英文 29 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
Handok Inc. : 製品パイプライン分析 Handok Inc. - Product Pipeline Review - 2015
出版日: 2015年08月31日 ページ情報: 英文 29 Pages
概要

Handok Inc.は、韓国に拠点を置く製薬・ヘルスケア企業です。同社では、処方薬、一般向けヘルス毛製品、医療機器、体外診断、サプリメント、医学的栄養製品の開発、製造、販売を行っています。

当レポートでは、Handok Inc.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Handok Inc.の基本情報

Handok Inc.の概要

  • 主要情報
  • 企業情報

Handok Inc.:R&Dの概要

  • 主な治療範囲

Handok Inc.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • パートナー製品
    • パートナー製品/併用療法モダリティ

Handok Inc.:パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

Handok Inc.:薬剤プロファイル

  • HL-1513
  • HL-2351
  • HL-2353
  • HL-5201
  • HL-5171
  • HL-5521

Handok Inc.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Handok Inc.:最近のパイプライン動向

Handok Inc.:休止中のプロジェクト

Handok Inc.:本社と子会社の所在地

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07535CDB

Summary

Global Markets Direct's, 'Handok Inc. - Product Pipeline Review - 2015', provides an overview of the Handok Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Handok Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Handok Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Handok Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Handok Inc.'s pipeline products

Reasons to buy

  • Evaluate Handok Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Handok Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Handok Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Handok Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Handok Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Handok Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Handok Inc. Snapshot
    • Handok Inc. Overview
    • Key Information
    • Key Facts
  • Handok Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Handok Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Handok Inc. - Pipeline Products Glance
    • Handok Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Handok Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Handok Inc. - Drug Profiles
    • HL-1513
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HL-2351
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HL-2353
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HL-5201
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HL-5171
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HL-5521
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Handok Inc. - Pipeline Analysis
    • Handok Inc. - Pipeline Products by Target
    • Handok Inc. - Pipeline Products by Route of Administration
    • Handok Inc. - Pipeline Products by Molecule Type
    • Handok Inc. - Pipeline Products by Mechanism of Action
  • Handok Inc. - Recent Pipeline Updates
  • Handok Inc. - Dormant Projects
  • Handok Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Handok Inc., Key Information
  • Handok Inc., Key Facts
  • Handok Inc. - Pipeline by Indication, 2015
  • Handok Inc. - Pipeline by Stage of Development, 2015
  • Handok Inc. - Monotherapy Products in Pipeline, 2015
  • Handok Inc. - Partnered Products in Pipeline, 2015
  • Handok Inc. - Partnered Products/ Combination Treatment Modalities, 2015
  • Handok Inc. - Phase I, 2015
  • Handok Inc. - Preclinical, 2015
  • Handok Inc. - Discovery, 2015
  • Handok Inc. - Pipeline by Target, 2015
  • Handok Inc. - Pipeline by Route of Administration, 2015
  • Handok Inc. - Pipeline by Molecule Type, 2015
  • Handok Inc. - Pipeline Products by Mechanism of Action, 2015
  • Handok Inc. - Recent Pipeline Updates, 2015
  • Handok Inc. - Dormant Developmental Projects,2015
  • Handok Inc., Other Locations

List of Figures

  • Handok Inc. - Pipeline by Top 10 Indication, 2015
  • Handok Inc. - Pipeline by Stage of Development, 2015
  • Handok Inc. - Monotherapy Products in Pipeline, 2015
  • Handok Inc. - Partnered Products in Pipeline, 2015
  • Handok Inc. - Pipeline by Top 10 Target, 2015
  • Handok Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Handok Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top